These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9545113)

  • 21. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genes that characterize T3-predominant Graves' thyroid tissues.
    Matsumoto C; Ito M; Yamada H; Yamakawa N; Yoshida H; Date A; Watanabe M; Hidaka Y; Iwatani Y; Miyauchi A; Takano T
    Eur J Endocrinol; 2013 Feb; 168(2):137-44. PubMed ID: 23109646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
    Fujishima A; Sato A; Miura H; Shimoda Y; Kameyama S; Ariake C; Adachi H; Fukuoka Y; Terada Y
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):344. PubMed ID: 32493403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
    Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
    Ito M; Toyoda N; Nomura E; Takamura Y; Amino N; Iwasaka T; Takamatsu J; Miyauchi A; Nishikawa M
    Eur J Endocrinol; 2011 Jan; 164(1):95-100. PubMed ID: 20937676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes of gastrin levels in autoimmune thyroid disorders. Part I: Thyroid functions and gastrin levels].
    Watatani Y; Aoki N
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):171-82. PubMed ID: 6548196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
    Kawamura S; Kishino B; Tajima K; Mashita K; Tarui S
    J Clin Endocrinol Metab; 1983 Mar; 56(3):507-12. PubMed ID: 6185525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
    Hidaka Y; Okumura M; Fukata S; Shimaoka Y; Takeoka K; Tada H; Kuma K; Amino N
    Thyroid; 1999 Feb; 9(2):149-53. PubMed ID: 10090314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
    Wenzel KW; Lente JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
    Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.